Home - Products - Metabolic Enzyme/Protease - Fatty Acid Synthase - UCM05

UCM05

UCM05

Catalog No. M33764

UCM05 (G28UCM) is a potent inhibitor of fatty acid synthase (FASN) with efficacy against HER2+ breast cancer xenografts, including cell lines resistant to anti-HER2 drugs .

Size	Price / USD	Stock	Quantity
2MG	52	In Stock
5MG	76	In Stock
10MG	132	In Stock
25MG	266	In Stock
50MG	419	In Stock
100MG	605	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

UCM05
Brief Description
Description
Storage
Note

Research use only, not for human use.
Reference

1. Teresa Puig, et al. A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines. Breast Cancer Res. 2011;13(6):R131.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Orlistat

Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.
UCM05

UCM05 (G28UCM) is a potent inhibitor of fatty acid synthase (FASN) with efficacy against HER2+ breast cancer xenografts, including cell lines resistant to anti-HER2 drugs .
trans-C75

trans-C75 is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN).

Sign In Join Free